Adding the new calcium antagonist mibefradil to patients receiving long-term β-blocker therapy results in improved antianginal and antiischemic efficacy

✍ Scribed by Adam Schneeweiss; Isaac Kobrin; Vincent Charlon; Abraham Caspi; Alon Marmor; Samuel Sclarovsky; Leonardo Reisin; Zvi Zchlesinger

• Book ID: 117010847
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 139 KB
• Volume: 135
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/s0002-8703(98)70093-6